Community

The Robert Larner, M.D. College of Medicine at the University of Vermont has a remarkable community that provides ample opportunities to connect with fellow graduate students, postdocs, staff, and faculty. Offerings include workshops, conferences, events and seminars to bring together the perspectives of our diverse specialties. It is important to share your voice and feel heard as well as get involved with our Larner Community. 

Calendars of Events

Social Media Connections

SocialMedia.pexels-tracy-le-blanc-607812

UVM Handshake, UVM Connect, LinkedIn, Instagram, Twitter. . . find our social media communities by checking out these social media platforms here

Cunniff Presents New Cancer Research at iMig Conference

August 3, 2023 by Lucy Gardner Carson

(AUGUST 3, 2023) At the 2023 International Mesothelioma Interest Group (iMig) conference in June, Brian Cunniff, Ph.D., assistant professor of pathology, presented early experience with “an exciting new therapeutic option for patients suffering with mesothelioma” to a global audience of clinicians, scientists, and allied professionals, according to Business Wire.

Brian Cunniff, Ph.D., assistant professor of pathology and laboratory medicine and chief science officer for RS Oncology

(AUGUST 3, 2023) At the 2023 International Mesothelioma Interest Group (iMig) conference hosted in Lille, France, in June, Brian Cunniff, Ph.D., assistant professor of pathology and laboratory medicine and chief science officer for RS Oncology (RSO), presented early experience with “an exciting new therapeutic option for patients suffering with mesothelioma” to a global audience of clinicians, scientists, and allied professionals, according to Business Wire.

“RSO-021 is an exciting new therapeutic option for patients suffering with mesothelioma,” Cunniff said. “RSO-021 exploits a universal vulnerability of tumor cells through a novel mechanism of action, leaving tumor cells unable to clear toxic waste products. We are excited to see our laboratory findings translated to patients in collaboration with RS Oncology.”

Watch a short clip from the symposium in which Dr. Cunniff explains the discovery of PRX3 and its role in cancer tumors. 

Read full story at Business Wire